The Impact of Very Late Antigen 4 Polymorphism on Drug Responsiveness in Patients with Multiple Sclerosis Initiation. IRAQI JMS. 2022;20(1). Accessed March 18, 2026. https://www.iraqijms.com/index.php/jms/article/view/818